Nabla Bio
June 25, 2026
Theater 2
Type: Company Presentation
Focus Area:
AI and Digital Health
Nabla Bio is a biomolecular AI company advancing JAM-2, a generative platform for de novo biologics design. Nabla continues to partner with leading biopharma companies through platform licensing and program-based collaborations, providing access to the JAM-2 background model alongside custom model development and new capability builds. The company is headquartered in Cambridge, MA.
Company HQ City:
Cambridge
Company HQ State:
Massachussetts
Company HQ Country:
United States
Year Founded:
2020
Lead Product in Development:
We're a partner focused business, and focus on partnering our platform to broadly enable our partner's pipelines through frontier AI models and integrated wet-labs. We don't have a lead product of our own.
CEO
Surge Biswas
Development Phase of Lead Product
Pre-Clinical
When you expect your next catalyst update?
November 2026
What is your next catalyst (value inflection) update?
Large multi-year AI x Bio collaboration with Top 10 pharma
Primary Speaker
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}